首页> Expert opinion on pharmacotherapy> The efficacy and safety of adding either vildagliptin or glimepiride to ongoing metformin therapy in patients with type 2 diabetes mellitus

The efficacy and safety of adding either vildagliptin or glimepiride to ongoing metformin therapy in patients with type 2 diabetes mellitus

导出原文传递

翻译打印收藏纠错

第一作者： Kim, Gyuri

作者： Kim, Gyuri ^[1] ; Oh, Sewon ; Jin, Sang-Man ; Hur, Kyu Yeon ; Kim, Jae Hyeon ; Lee, Moon-Kyu

作者单位： Sungkyunkwan Univ, Div Endocrinol & Metab, Samsung Med Ctr, Dept Med,Sch Med, 81 Irwon Ro, Seoul ^[1]

关键词 Continuous glucose monitoring flow-mediated dilatation glimepiride mixed-meal tolerance test oxidative stress vildagliptin type 2 diabetes

发布时间 2020-06-02

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览2

Expert opinion on pharmacotherapy

2017年18卷7/12期

1179-1186页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览2

Expert opinion on pharmacotherapy

2017年18卷7/12期

1179-1186页

检索历史清除

The efficacy and safety of adding either vildagliptin or glimepiride to ongoing metformin therapy in patients with type 2 diabetes mellitus

Expert opinion on pharmacotherapy

相似文献

同项目论文

Expert opinion on pharmacotherapy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

The efficacy and safety of adding either vildagliptin or glimepiride to ongoing metformin therapy in patients with type 2 diabetes mellitus

Expert opinion on pharmacotherapy

相似文献

同项目论文

Expert opinion on pharmacotherapy

相关期刊

检索历史清除